We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Reference sheet · Research Peptides · CPC catalog code ELH-001
This sequence carries terminal or reporter modifications (NH2), so no molecular formula or weight is published here — the modified mass must come from the lot certificate of analysis. Residue composition and charge describe the peptide backbone only. Composition figures above are derived arithmetically from the published sequence for the unmodified free peptide. Salt forms (commonly trifluoroacetate or acetate), amidation, and other modifications shift the observed mass — always reconcile against the current lot certificate of analysis.
Volumes for a 1 mg vial of Egg Laying Hormone at common working concentrations. Add solvent slowly down the vial wall and swirl — do not vortex or shake.
Reference standards in the Research Peptides class are typically shipped as lyophilized powder and stored desiccated at −20 °C protected from light. Once reconstituted in bacteriostatic water or the assay-appropriate buffer, aliquot and store at −80 °C to minimize freeze–thaw cycles. Confirm handling requirements against your institutional biosafety and radiation protocols before use.
Egg Laying Hormone sits within the Research Peptides research class (CPC reference ELH-001). This entry is a chemically defined synthetic peptide provided as a reference standard. Mechanism of action is program-specific and depends on the assay in which the sequence is deployed. Investigators typically incorporate Egg Laying Hormone as a reference standard, tool ligand, or substrate in the assay contexts listed above. Assay-appropriate readouts vary by research program.
Egg Laying Hormone (CPC catalog code ELH-001) is a synthetic general research peptide reference standard in the research peptides category. It is provided as a lyophilized ~1 mg vial for in-vitro research use only.
Published and internal research programs use Egg Laying Hormone as a reference standard in research peptides workflows — for example, reference-standard use in biochemical and cellular assays and structure–activity relationship (sar) work. Human clinical evidence is not established.
No. Egg Laying Hormone is a research-grade reference peptide and is not approved by the FDA or any national regulator for human or veterinary therapeutic use. It is offered exclusively for in-vitro laboratory research and does not ship to the United States for consumer use.
In a research peptides workflow, Egg Laying Hormone is reconstituted in sterile buffer or DMSO (solubility-dependent) and applied in the researcher's chosen assay format. Assay-appropriate readouts vary by research program.
Other reference standards in the same class — commonly cross-referenced during assay design and comparator selection.